NR2F1 and melanoma: Notably, Tiago and colleagues also reported that melanomas in aged mice exhibited elevated NR2F1 levels (19), aligning with prior observations that aged mice showed a poorer response to BRAFi + MEKi than did their younger counterparts (8, 19).